Pre Pen (Penicilloyl-polylysine) - Use, Dose, Administration

Penicilloyl-polylysine (Pre-Pen) is a reagent for penicillin allergy skin testing. It binds specifically to the IgE that is released in response to penicillins.

Penicilloyl-polylysine (Pre-Pen) Uses:

  • Adjunct in assessing the risk of administering penicillin (penicillin G or benzylpenicillin) in suspected patients of clinical penicillin hypersensitivity
  • Off Label Use of Penicilloyl-polylysine in Adults:

    • Adjunct in the assessment of hypersensitivity to other beta-lactam antibiotics (penicillins and cephalosporins) to determine the safety of penicillin in patients with a history of reaction to cephalosporins

Penicilloyl-polylysine (Pre-Pen) Dose in Adults

Penicilloyl-polylysine (Pre-Pen) Dose in the Diagnostic aid for the detection of penicillin allergy:

Note:

  • Benzylpenicilloyl polylysine should always be applied initially via the puncture technique.
  • Do not inject intradermally to patients who have a positive reaction to the puncture test.
  • Puncture test:

    • Small drop of the skin test solution is applied by using a 22- to 28-gauge needle and make a single shallow puncture of the epidermis through the drop of solution.
    • A positive reaction consists of a pale wheal surrounding the puncture site which develops within 10 minutes and ranges from 5-15 mm or more in diameter (wheal may be surrounded by erythema and variable degrees of itching).
    • If a positive response is evident, the solution should be wiped off immediately.
    • If the puncture test is negative or equivocal (<5 mm wheal, with little or no erythema and no itching) 15 minutes following the puncture test, an intradermal test may be performed.
    • Intradermal test:

      • Using a 0.5-1 mL tuberculin syringe with a 3/8 to 5/8 inch, 26- to 30-gauge short bevel needle, inject a volume of skin test solution sufficient to raise a small intradermal bleb about 3 mm in diameter intradermally, in duplicate at least 2 cm apart.
      • A control of 0.9% sodium chloride or allergen-diluting solution should be injected at least 5 cm from the antigen test site.
      • Most skin responses to the intradermal test will develop within 5-15 minutes.
      • A response to the skin test is read at 20 minutes.
  • Interpretation of intradermal test:

    • (-) Negative:

      • No increase in the size of an original bleb or no greater reaction compared to the control site
    • (±) Ambiguous:

      • Wheal only slightly larger than original bleb with or without erythematous flare and slightly larger than control site; OR discordance between duplicate test sites
    • (+) Positive:

      • Itching and a marked increase in the size of original bleb to ≥5 mm. Wheal may exhibit pseudopods and be >20 mm in diameter.
    • Control site should be reactionless. If wheal of size >2-3 mm develops at the control site, repeat the test. If same reaction occurs, consultation is necessary.

Penicilloyl-polylysine (Pre-Pen) Dose in Childrens

Penicilloyl-polylysine (Pre-Pen) Dose in the Diagnostic aid for the detection of penicillin allergy (penicillin G and benzylpenicillin):

  • Children and Adolescents:

  • Note:

    • Benzylpenicilloyl polylysine should always be administered first via the puncture technique.
    • Do not inject intradermally to patients who have positive reactions to a puncture test.
  • Puncture scratch test:

    • A small drop of the skin test solution is applied by using a 22- to 28-gauge needle and make a single shallow puncture of the epidermis through the drop of solution.
    • A positive reaction consists of a pale wheal surrounding the puncture site which develops within 10 minutes and ranges from 5 to 15 mm or more in diameter (wheal may be surrounded by erythema and variable degrees of itching).
    • If a positive response is evident, the solution should be wiped off immediately.
    • If the puncture test is negative or equivocal (<5 mm wheal, with little or no erythema and no itching) 15 minutes following the puncture test, an intradermal test may be performed.
  • Intradermal test:

    • Using a 0.5 to 1 mL tuberculin syringe with a 3/8 - to 5/8 -inch, 26- to 30-gauge short bevel needle; inject a volume of skin test solution sufficient to raise a small intradermal bleb about 3 mm in diameter intradermally and duplicate at least 2 cm apart.
    • Control of 0.9% sodium chloride or allergen-diluting solution should be injected at least 5 cm from the antigen test site.
    • Most skin responses to the intradermal test will develop within 5 to 15 minutes.
    • A response to the skin test is read at 20 minutes.
  • Interpretation of the intradermal test:

    • (-) Negative:

      • No increase in the size of an original bleb or no greater reaction compared to the control site.
    • (±) Ambiguous:

      • Wheal is only slightly larger than original bleb with or without erythematous flare and slightly larger than the control site, or discordance between duplicate test sites.
    • (+) Positive:

      • Itching and a marked increase in the size of the original bleb to ≥5 mm. Wheal may exhibit pseudopods and be >20 mm in diameter.
    • The control site should be reactionless. If wheal of size >2 to 3 mm develops at the control site, repeat the test. If the same reaction occurs, consultation is necessary.

Pregnancy Risk Factor C

  • Studies on animal reproduction have not been conducted with benzylpenicilloyl-polylysine.
  • The Centers for Disease Control and Prevention states that penicillin skin testing can help to determine if a pregnant patient with syphilis is susceptible to penicillin hypersensitivity. Penicillin is the only proven alternative in this population.

Pre-Pen Dose in Kidney Disease:

  • No dosage adjustment provided in the drug manufacturer’s labeling.

Pre-Pen Dose in Liver Disease:

  • No dosage adjustment provided in the drug manufacturer’s labeling.

Side effects of Penicilloyl-polylysine (Pre-Pen):

  • Cardiovascular:

    • Hypotension
  • Dermatologic:

    • Erythema
    • Pruritus
    • Urticaria (Including Local Reaction At Skin Test Site)
  • Hypersensitivity:

    • Angioedema
    • Hypersensitivity Reaction (Including Anaphylaxis; Rare)
  • Local:

    • Local Inflammation (Intense; At Skin Test Site)
  • Respiratory:

    • Dyspnea

Contraindications to Penicilloyl-polylysine:

  • A previous skin test with benzylpenicilloylpolylysine showed a marked or systemic reaction;
  • Penicillin hypersensitivity patients should not be tested again

Warnings & Precautions

  • Allergy reactions

    • Penicillin skin testing has been linked to rare systemic allergic reactions (including anaphylaxis).
    • Penicillin skin testing should only be performed by qualified medical personnel under the supervision and direction of a doctor. Only use Epinephrine-ready healthcare facilities for testing.
    • To reduce allergic reactions, the manufacturer recommends that intradermal testing be done before puncture skin testing.
  • Severe penicillin allergy:

    • Penicillin skin testing should not be performed on patients with a history of severe penicillin allergy.

Penicilloyl-polylysine: Drug Interaction

Risk Factor D (Consider therapy modification)

Alpha-/Beta-Agonists

May diminish the diagnostic effect of Benzylpenicilloyl Polylysine. Management: Consider use of a histamine skin test as a positive control to assess a patient's ability to mount a wheal and flare response. Exceptions: EPINEPHrine (Nasal); EPINEPHrine (Oral Inhalation); Isometheptene.

Alpha1-Agonists

May diminish the diagnostic effect of Benzylpenicilloyl Polylysine. Management: Consider use of a histamine skin test as a positive control to assess a patient's ability to mount a wheal and flare response. Exceptions: Naphazoline (Nasal); Naphazoline (Ophthalmic); Oxymetazoline (Nasal); Phenylephrine (Nasal); Phenylephrine (Ophthalmic); Phenylephrine (Topical); Propylhexedrine; Xylometazoline.

Antihistamines:

May diminish the diagnostic effect of Benzylpenicilloyl Polylysine. Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.

Monitoring Parameters:

None mentioned.

How to administer Penicilloyl-polylysine (Pre-Pen)?

  • Puncture test:

    • Administer initially by puncture technique on the inner volar aspect of the forearm, followed by an intradermal injection only in patients with a negative reaction.
  • Intradermal:

    • Do not administer intradermally to patients with a positive skin reaction (wheal of 5 to 15 mm or more in diameter) after skin puncture test.
    • Inject the intradermal test solution on the upper, outer arm, below the deltoid muscle in the event a severe hypersensitivity reaction occurs and a tourniquet needs to be applied.
    • During the skin test, immediate treatment with epinephrine should also be available.

Mechanism of action of (Pre-Pen) Penicilloyl-polylysine:

  • Benzylpenicilloyl polylysine, a conjugate of the benzylpenicilloyl structural group (hapten) and the poly-l-lysine carrier (protein), is an antigen which reacts with benzylpenicilloyl IgE antibodies to initiate the release of chemical mediators, thereby producing type I (immediate or accelerated) hypersensitivity/urticarial reactions in patients hypersensitive to penicillins.

International Brands of Penicilloyl-polylysine:

  • Pre-Pen

Penicilloyl-polylysine Brand Names in Pakistan:

No Brands Available in Pakistan.

Comments

NO Comments Found